<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1224</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Polymorphic gene tlr2 markers in latent syphilis and seroresistance</article-title><trans-title-group xml:lang="ru"><trans-title>Полиморфные маркеры гена tlr2 при скрытом сифилисе и серорезистентности</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Barycheva</surname><given-names>L Yu</given-names></name><name xml:lang="ru"><surname>Барычева</surname><given-names>Л Ю</given-names></name></name-alternatives><email>info@rusalljournal.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Minasyan</surname><given-names>M M</given-names></name><name xml:lang="ru"><surname>Минасян</surname><given-names>М М</given-names></name></name-alternatives><email>info@rusalljournal.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ohon’ko</surname><given-names>I A</given-names></name><name xml:lang="ru"><surname>Охонько</surname><given-names>И А</given-names></name></name-alternatives><email>info@rusalljournal.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">FGBO VO «Stavropol state medical university» Health Ministry of Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Ставропольский государственный медицинский университет» Министерства Здравоохранения Российской Федерации</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2019</year></pub-date><volume>16</volume><issue>1S</issue><issue-title xml:lang="en">VOL 16, NOS1 (2019)</issue-title><issue-title xml:lang="ru">ТОМ 16, №S1 (2019)</issue-title><fpage>23</fpage><lpage>25</lpage><history><date date-type="received" iso-8601-date="2020-04-02"><day>02</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, Фармарус Принт Медиа</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2021-11-01"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/1224">https://rusalljournal.ru/raj/article/view/1224</self-uri><abstract xml:lang="en"><p>.</p></abstract><trans-abstract xml:lang="ru"><p>.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis / Petruccioli E [et al] // European Respiratory Journal. - 2016. - Vol.48. -P. 1751-1763.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Medvedev A.E. Toll-Like Receptor Polymorphisms, Inflammatory and Infectious Diseases, Allergies, and Cancer / A.E. Medvedev] // J. Interferon Cytokine Res. - 2013. - Vol.33. - №9. - P. 467-484.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Role of Toll-Like Receptors in Tuberculosis Infection / O.O. Biyikli [et al] // Jundishapur J. Microbiol. -2016. - Vol. 9. - №10: e20224. Published: Oct. 2016. ULR: https://www.ncbi.nlm.nih.gov/pmc/ articles/ PMC5136443/</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>The presence of functionally relevant toll-like receptor polymorphisms does not significantly correlate with development or outcome of sepsis / P. Ahmad-Nejad [et al] // Genet. Test Mol. Biomarkers. - 2011. - Vol.15. - P. 645-651.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Toll-like receptor 2 R753Q polymorphisms are associated with an increased risk of infective endocarditis / J. Bustamante [et al] // Rev. Esp. Cardiol. - 2011. -Vol. 64. - №11. - P.1056-1059.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Misch, E. A. Toll-like receptor polymorphisms and susceptibility to human disease / E. A. Misch, T. R. Hawn // Clinical Science. - 2008. - Vol. 114. - P. 347-360.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Zhang, C. Y. Clinical analysis of serofast patients among syphilitic patients / C. Y. Zhang // Lab. Med. Clin. -2013. - Vol. 10, № 7. - P. 887-88</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Christodoulides A. Spirochetal Lipoproteins and Immune Evasion / A. Christodoulides, A. Boyadjian, T. Kelesidis // Front. Immunol. - 2017. - Vol. 8. -Art. № 364. DOI: 10 3389/fimmn 2017 00364</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins / M. Ioana, B. Ferwerda, Plantinga T. S. [et al.] // Infect. Immun. - 2012. - Vol. 80, № 5. - P. 1917-1922.</mixed-citation></ref></ref-list></back></article>
